Location: Miami, FL
CIK: 0001325083 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value: $64.89M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2,067,160 | $20.53M | 31.6% | $5.93 | +19.1% | COM | 01438T106 |
| — | Biohaven Pharmactl Hldg Co L | 450,422 | $6.153M | 9.5% | $32.04 | — | COM | G11196105 |
| — | Avadel Pharmaceuticals Plc | 500,000 | $4.58M | 7.1% | $7.16 | — | Call | 05337M104 |
| — | Verona Pharma | 200,000 | $4.016M | 6.2% | $22.97 | — | SPONSORED ADS | 925050106 |
| GDX | Vaneck Gold Miners ETF | 91,850 | $2.971M | 4.6% | $28.66 | — | Gold Miners ETF | 92189F106 |
| ENTX | Entera Bio Ltd | 2,484,275 | $2.882M | 4.4% | $3.46 | -71.1% | SHS | M40527109 |
| — | Applied Therapeutics Inc | 3,450,000 | $2.798M | 4.3% | $5.66 | — | COM | 03828A101 |
| SIL | Global X Silver Miners ETF 37954Y848 | 89,700 | $2.756M | 4.2% | $28.17 | — | Global X Silver | 37954Y848 |
| GDXJ | Vaneck Junior Gold Miners ETF | 53,150 | $2.099M | 3.2% | $35.65 | — | Junior Hold Mine | 92189F791 |
| OCUL | Ocular Therapeutix Inc. | 200,000 | $1.504M | 2.3% | $4.75 | 0.0% | COM | 67576A100 |
| — | OSISKO GOLD ROYALTIES LTD | 400,000 | $1.272M | 2.0% | $2.88 | — | COM | 68827L101 |
| TMO | Thermo Fischer Scientific Inc | 2,100 | $1.214M | 1.9% | $471.13 | +18.6% | COM | 883556102 |
| BAH | Booz Allen Hamilton HLDG COR | 13,000 | $1.205M | 1.9% | $76.36 | +17.3% | CL A | 099502106 |
| V | Visa | 4,850 | $1.093M | 1.7% | $203.18 | +7.2% | COM CL A | 92826C839 |
| CVS | CVS Health Corp | 14,500 | $1.077M | 1.7% | $62.28 | +20.7% | COM | 126650100 |
| — | Silvercrest Metals Inc CAD | 170,000 | $1.044M | 1.6% | $6.14 | — | COM | 828363101 |
| — | Omega Therapeutics Inc. | 173,010 | $1.043M | 1.6% | $6.03 | — | COM | 68217N105 |
| SA | SEABRIDGE GOLD INC | 80,000 | $1.036M | 1.6% | $14.95 | -17.3% | COM | 811916105 |
| FNV | Franco Nev Corp CAD | 7,000 | $1.021M | 1.6% | $135.73 | 0.0% | COM | 351858105 |
| MO | Altria Group Inc | 22,700 | $1.013M | 1.6% | $30.41 | +19.3% | COM | 02209S103 |
| NOC | Northrop Grumman Corp | 2,165 | $1M | 1.5% | $442.02 | 0.0% | COM | 666807102 |
| — | Orgenesis, Inc. | 634,738 | $749K | 1.2% | $6.08 | — | COM | 68619K105 |
| ALT | Altimmune Inc | 173,864 | $734K | 1.1% | $12.66 | -6.2% | COM NEW | 02155H200 |
| OCUL | Ocular Therapeutix Inc. | 95,800 | $505K | 0.8% | $4.75 | 0.0% | Call | 67576A100 |
| IRD | Ocuphire Pharma Inc. | 100,000 | $375K | 0.6% | $3.59 | 0.0% | COM | 67577R102 |
| — | HOOKIPA PHARMA | 300,000 | $221K | 0.3% | $0.75 | — | COM | 43906K100 |